FDA Inspection
Vista Pharmaceuticals LimitedVista Pharmaceuticals Limited – FDA Inspection, Feb 9, 2018
Record Details
This FDA Inspection record concerns Vista Pharmaceuticals Limited, with an inspection on February 9, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · fcf6b54f-7a29-4f66-a999-f82f149c611b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1040372
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
10- 21 CFR 211.58Buildings not maintained in good state of repair
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.125(a)Strict control not exercised over labeling issued
- 21 CFR 211.160(b)(4)Test devices not meeting specifications
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vista Pharmaceuticals Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 23, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 5, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Vista Pharmaceuticals Limited
- FDA Inspection 991307 - 2016-09-23
- FDA Inspection 632974 - 2009-11-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.